NO20092101L - Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav. - Google Patents
Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav.Info
- Publication number
- NO20092101L NO20092101L NO20092101A NO20092101A NO20092101L NO 20092101 L NO20092101 L NO 20092101L NO 20092101 A NO20092101 A NO 20092101A NO 20092101 A NO20092101 A NO 20092101A NO 20092101 L NO20092101 L NO 20092101L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- ocular devices
- manufacture
- devices
- ocular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Eyeglasses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Materials For Medical Uses (AREA)
Abstract
Beskrevet heri er stabile okulære innretninger som immobiliserer og leverer vedvarende bioaktive midler til øyet over tid. Også beskrevet heri er fremgangsmåter for fremstiling og anvendelse av de okulære innretningene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86442806P | 2006-11-06 | 2006-11-06 | |
PCT/US2007/023239 WO2008073193A2 (en) | 2006-11-06 | 2007-11-05 | Ocular devices and methods of making and using thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092101L true NO20092101L (no) | 2009-06-05 |
Family
ID=39284102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092101A NO20092101L (no) | 2006-11-06 | 2009-05-28 | Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080124376A1 (no) |
EP (1) | EP2094235A2 (no) |
JP (1) | JP5586956B2 (no) |
KR (1) | KR101454041B1 (no) |
CN (1) | CN101534793A (no) |
AR (1) | AR063561A1 (no) |
AU (1) | AU2007332930B2 (no) |
BR (1) | BRPI0718543A2 (no) |
CA (2) | CA2668576C (no) |
MX (1) | MX2009004365A (no) |
NO (1) | NO20092101L (no) |
RU (1) | RU2450802C2 (no) |
TW (1) | TWI476022B (no) |
WO (1) | WO2008073193A2 (no) |
ZA (1) | ZA200901842B (no) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090088846A1 (en) | 2007-04-17 | 2009-04-02 | David Myung | Hydrogel arthroplasty device |
US10064819B2 (en) | 2008-05-12 | 2018-09-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9095404B2 (en) | 2008-05-12 | 2015-08-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9877973B2 (en) | 2008-05-12 | 2018-01-30 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
EP2276439A4 (en) | 2008-05-12 | 2013-11-27 | Univ Utah Res Found | INTRAOCULAR DRUG DELIVERY DEVICE AND ASSOCIATED METHODS |
US20120209396A1 (en) | 2008-07-07 | 2012-08-16 | David Myung | Orthopedic implants having gradient polymer alloys |
TWI531362B (zh) | 2008-07-21 | 2016-05-01 | 艾爾康股份有限公司 | 具有治療劑遞送能力之眼科裝置 |
JP5721267B2 (ja) | 2008-07-21 | 2015-05-20 | ノバルティス アーゲー | シリコーンハイドロゲルコンタクトレンズを製造する方法 |
CA2731698A1 (en) | 2008-08-05 | 2010-02-11 | Biomimedica, Inc. | Polyurethane-grafted hydrogels |
TWI506333B (zh) * | 2008-12-05 | 2015-11-01 | Novartis Ag | 用以傳遞疏水性舒適劑之眼用裝置及其製造方法 |
AU2010213612B2 (en) | 2009-02-12 | 2015-04-30 | Incept, Llc | Drug delivery through hydrogel plugs |
JP5247597B2 (ja) | 2009-06-03 | 2013-07-24 | 株式会社シード | 湿潤性ハイドロゲルコンタクトレンズ及びその製造方法 |
US9522980B2 (en) | 2010-05-06 | 2016-12-20 | Johnson & Johnson Vision Care, Inc. | Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same |
KR101819873B1 (ko) * | 2010-07-30 | 2018-01-17 | 노파르티스 아게 | 가교된 친수성 코팅을 갖는 실리콘 히드로겔 렌즈 |
CA2808528A1 (en) | 2010-08-27 | 2012-03-01 | Biomimedica, Inc. | Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same |
US20130203813A1 (en) | 2011-05-04 | 2013-08-08 | Johnson & Johnson Vision Care, Inc. | Medical devices having homogeneous charge density and methods for making same |
US9170349B2 (en) | 2011-05-04 | 2015-10-27 | Johnson & Johnson Vision Care, Inc. | Medical devices having homogeneous charge density and methods for making same |
CA2838242C (en) | 2011-06-09 | 2016-05-17 | Novartis Ag | Silicone hydrogel lenses with nano-textured surfaces |
BR112014001444A2 (pt) * | 2011-07-20 | 2017-07-18 | Univ Brigham Young | compostos hidrofóbicos de ceragenina e dispositivos que incorporam os mesmos |
US10226417B2 (en) | 2011-09-16 | 2019-03-12 | Peter Jarrett | Drug delivery systems and applications |
EP2763707B1 (en) | 2011-10-03 | 2018-03-28 | Hyalex Orthopaedics, Inc. | Polymeric adhesive for anchoring compliant materials to another surface |
WO2013078284A1 (en) | 2011-11-21 | 2013-05-30 | Biomimedica, Inc. | Systems, devices, and methods for anchoring orthopaedic implants to bone |
EP2846634A2 (en) | 2012-05-02 | 2015-03-18 | Brigham Young University | Ceragenin particulate materials and methods for making same |
US10073192B2 (en) | 2012-05-25 | 2018-09-11 | Johnson & Johnson Vision Care, Inc. | Polymers and nanogel materials and methods for making and using the same |
US9297929B2 (en) | 2012-05-25 | 2016-03-29 | Johnson & Johnson Vision Care, Inc. | Contact lenses comprising water soluble N-(2 hydroxyalkyl) (meth)acrylamide polymers or copolymers |
US9244196B2 (en) | 2012-05-25 | 2016-01-26 | Johnson & Johnson Vision Care, Inc. | Polymers and nanogel materials and methods for making and using the same |
WO2014038004A1 (ja) * | 2012-09-05 | 2014-03-13 | 株式会社メニコン | 薬物徐放性眼用レンズ及びその製造方法 |
EP2932314B1 (en) | 2012-12-17 | 2017-02-01 | Novartis AG | Method for making improved uv-absorbing ophthalmic lenses |
US9161598B2 (en) | 2012-12-21 | 2015-10-20 | Coopervision International Holding Company, Lp | Ophthalmic devices for delivery of beneficial agents |
US9248928B2 (en) | 2012-12-21 | 2016-02-02 | Coopervision International Holding Company, Lp | Methods of manufacturing contact lenses for delivery of beneficial agents |
US9498035B2 (en) | 2012-12-21 | 2016-11-22 | Coopervision International Holding Company, Lp | Silicone hydrogel contact lenses for sustained release of beneficial polymers |
EP2941253B1 (en) | 2013-01-07 | 2021-08-11 | Brigham Young University | Cationic steroid antimicrobial agents for use in treating cancer |
SG2013091087A (en) * | 2013-01-09 | 2014-08-28 | Johnson & Johnson Vision Care | Multi-piece insert device with glue seal for ophthalmic devices |
DK3517100T3 (da) * | 2013-02-01 | 2020-12-14 | Allergan Inc | Kunstige tårer omfattende natriumhyaluronat og carboxymethylcellulose |
US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US10568893B2 (en) | 2013-03-15 | 2020-02-25 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
CA2907082C (en) | 2013-03-15 | 2021-05-04 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
RU2686339C2 (ru) * | 2013-09-27 | 2019-04-25 | Новартис Аг | Композиции и способы дезинфекции и очищения контактных линз |
US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
EP3083216B1 (en) | 2013-12-17 | 2018-01-31 | Novartis AG | A silicone hydrogel lens with a crosslinked hydrophilic coating |
US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
CA2844321C (en) | 2014-02-27 | 2021-03-16 | Brigham Young University | Cationic steroidal antimicrobial compounds |
US10220045B2 (en) | 2014-03-13 | 2019-03-05 | Brigham Young University | Compositions and methods for forming stabilized compositions with reduced CSA agglomeration |
US10238665B2 (en) | 2014-06-26 | 2019-03-26 | Brigham Young University | Methods for treating fungal infections |
US10441595B2 (en) | 2014-06-26 | 2019-10-15 | Brigham Young University | Methods for treating fungal infections |
US10227376B2 (en) | 2014-08-22 | 2019-03-12 | Brigham Young University | Radiolabeled cationic steroid antimicrobials and diagnostic methods |
SG10201901379TA (en) | 2014-08-26 | 2019-03-28 | Novartis Ag | Method for applying stable coating on silicone hydrogel contact lenses |
US10155788B2 (en) | 2014-10-07 | 2018-12-18 | Brigham Young University | Cationic steroidal antimicrobial prodrug compositions and uses thereof |
US10370403B2 (en) | 2015-04-22 | 2019-08-06 | Brigham Young University | Methods for the synthesis of ceragenins |
US11077228B2 (en) | 2015-08-10 | 2021-08-03 | Hyalex Orthopaedics, Inc. | Interpenetrating polymer networks |
MY184638A (en) | 2015-12-15 | 2021-04-13 | Alcon Inc | Method for applying stable coating on silicone hydrogel contact lenses |
US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
US11256003B2 (en) | 2017-12-13 | 2022-02-22 | Alcon Inc. | Weekly and monthly disposable water gradient contact lenses |
US10869950B2 (en) | 2018-07-17 | 2020-12-22 | Hyalex Orthopaedics, Inc. | Ionic polymer compositions |
US20220187620A1 (en) * | 2020-12-15 | 2022-06-16 | Coopervision International Limited | Oleic acid-releasing contact lens |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL128305C (no) * | 1963-09-11 | |||
FR2402525A1 (fr) * | 1977-09-12 | 1979-04-06 | Toray Industries | Procede de fabrication de compositions de lentilles de contact molles et nouveaux produits ainsi obtenus |
US4444711A (en) * | 1981-12-21 | 1984-04-24 | Husky Injection Molding Systems Ltd. | Method of operating a two-shot injection-molding machine |
US4460534A (en) * | 1982-09-07 | 1984-07-17 | International Business Machines Corporation | Two-shot injection molding |
US4668506A (en) * | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
WO1989004153A1 (en) * | 1987-11-09 | 1989-05-18 | Chiron Ophthalmics Inc. | Implantation of prosthetic devices |
DE3875240T2 (de) * | 1988-04-09 | 1993-02-25 | Hewlett Packard Gmbh | Polyacrylamid-gel. |
US4983702A (en) * | 1988-09-28 | 1991-01-08 | Ciba-Geigy Corporation | Crosslinked siloxane-urethane polymer contact lens |
JP3085480B2 (ja) * | 1991-10-02 | 2000-09-11 | セイコーエプソン株式会社 | ホルモン徐放性コンタクトレンズ |
TW272976B (no) * | 1993-08-06 | 1996-03-21 | Ciba Geigy Ag | |
US5712356A (en) * | 1993-11-26 | 1998-01-27 | Ciba Vision Corporation | Cross-linkable copolymers and hydrogels |
AU1042495A (en) * | 1993-12-08 | 1995-06-27 | Vitaphore Corporation | Microsphere drug delivery system |
US5894002A (en) * | 1993-12-13 | 1999-04-13 | Ciba Vision Corporation | Process and apparatus for the manufacture of a contact lens |
US5843346A (en) * | 1994-06-30 | 1998-12-01 | Polymer Technology Corporation | Method of cast molding contact lenses |
US5760100B1 (en) * | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
US5665840A (en) * | 1994-11-18 | 1997-09-09 | Novartis Corporation | Polymeric networks from water-soluble prepolymers |
AU4620596A (en) * | 1995-02-03 | 1996-08-21 | Novartis Ag | Crosslinked polymers containing ester or amide groups |
TW349967B (en) * | 1995-02-03 | 1999-01-11 | Novartis Ag | Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor |
US5583463A (en) * | 1995-05-30 | 1996-12-10 | Micron Technology, Inc. | Redundant row fuse bank circuit |
WO1998017704A1 (en) * | 1996-10-21 | 1998-04-30 | Novartis Ag | Crosslinkable polymers |
TW425403B (en) * | 1997-02-04 | 2001-03-11 | Novartis Ag | Branched polyurethane (meth)acrylate prepolymers, opthal-mic mouldings derived therefrom and processes for their manufacture |
US6221303B1 (en) * | 1997-02-21 | 2001-04-24 | Novartis Ag | Ophthalmic mouldings |
US5981826A (en) * | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
US6011082A (en) * | 1997-06-02 | 2000-01-04 | Pharmacia & Upjohn Ab | Process for the modification of elastomers with surface interpreting polymer networks and elastomers formed therefrom |
WO1999014253A1 (en) * | 1997-09-16 | 1999-03-25 | Novartis Ag | Crosslinkable polyurea polymers |
TW429327B (en) * | 1997-10-21 | 2001-04-11 | Novartis Ag | Single mould alignment |
US6039913A (en) * | 1998-08-27 | 2000-03-21 | Novartis Ag | Process for the manufacture of an ophthalmic molding |
EP1002807A1 (en) * | 1998-11-20 | 2000-05-24 | Novartis AG | Functionalized resin derived from polyallylamine |
US6395756B2 (en) * | 1999-12-23 | 2002-05-28 | Novartis Ag | Use of ophthalmic agent |
CA2399022A1 (en) * | 2000-02-04 | 2001-08-09 | Supratek Pharma Inc. | Ligand for vascular endothelial growth factor receptor |
DE60103621T2 (de) * | 2000-03-24 | 2005-06-16 | Novartis Ag | Vernetzbare oder polymerisierbare präpolymere |
AR030341A1 (es) * | 2000-08-14 | 2003-08-20 | Novartis Ag | Articulos biomedicos moldeados |
US6511960B2 (en) * | 2001-01-05 | 2003-01-28 | Alphamed Pharmaceuticals Corp | Cromolyn for eye and ear infections |
US20030020870A1 (en) * | 2001-06-27 | 2003-01-30 | Zms, Llc | Biomedical molding materials from semi-solid precursors |
US20060100408A1 (en) * | 2002-03-11 | 2006-05-11 | Powell P M | Method for forming contact lenses comprising therapeutic agents |
DE60317797T2 (de) * | 2002-08-14 | 2008-10-30 | Novartis Ag | Strahlungshärtbare prepolymere |
US20040105880A1 (en) * | 2002-11-21 | 2004-06-03 | Turner Josephine Sara | Interpenetrating polymer network |
JP4379778B2 (ja) * | 2003-04-03 | 2009-12-09 | 株式会社シード | 薬物徐放性眼用レンズ |
JP4937491B2 (ja) * | 2003-04-03 | 2012-05-23 | 株式会社シード | カチオン性高分子ゲル及びそれを用いた薬物徐放性高分子ゲル |
WO2005015184A1 (en) * | 2003-07-30 | 2005-02-17 | Novartis Ag | Reflection hologram sensor in contact lens |
US7977430B2 (en) * | 2003-11-25 | 2011-07-12 | Novartis Ag | Crosslinkable polyurea prepolymers |
JP2008520781A (ja) * | 2004-11-22 | 2008-06-19 | ノバルティス アクチエンゲゼルシャフト | 架橋性ポリ(オキシアルキレン)含有ポリアミドプレポリマー |
GB0502790D0 (en) * | 2005-02-10 | 2005-03-16 | Univ London Pharmacy | Solid dispersion of hydrophobic bioactive |
US9804295B2 (en) * | 2005-05-05 | 2017-10-31 | Novartis Ag | Ophthalmic devices for sustained delivery of active compounds |
-
2007
- 2007-11-05 EP EP20070870843 patent/EP2094235A2/en not_active Ceased
- 2007-11-05 CA CA2668576A patent/CA2668576C/en not_active Expired - Fee Related
- 2007-11-05 JP JP2009535347A patent/JP5586956B2/ja not_active Expired - Fee Related
- 2007-11-05 MX MX2009004365A patent/MX2009004365A/es active IP Right Grant
- 2007-11-05 RU RU2009121444/15A patent/RU2450802C2/ru not_active IP Right Cessation
- 2007-11-05 WO PCT/US2007/023239 patent/WO2008073193A2/en active Application Filing
- 2007-11-05 TW TW096141735A patent/TWI476022B/zh not_active IP Right Cessation
- 2007-11-05 CA CA2914805A patent/CA2914805C/en not_active Expired - Fee Related
- 2007-11-05 AU AU2007332930A patent/AU2007332930B2/en not_active Ceased
- 2007-11-05 KR KR1020097009197A patent/KR101454041B1/ko active IP Right Grant
- 2007-11-05 BR BRPI0718543-0A2A patent/BRPI0718543A2/pt not_active IP Right Cessation
- 2007-11-05 CN CNA2007800412616A patent/CN101534793A/zh active Pending
- 2007-11-05 US US11/934,817 patent/US20080124376A1/en not_active Abandoned
- 2007-11-05 AR ARP070104915A patent/AR063561A1/es not_active Application Discontinuation
-
2009
- 2009-03-16 ZA ZA200901842A patent/ZA200901842B/xx unknown
- 2009-05-28 NO NO20092101A patent/NO20092101L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TWI476022B (zh) | 2015-03-11 |
AR063561A1 (es) | 2009-02-04 |
BRPI0718543A2 (pt) | 2013-11-12 |
AU2007332930A1 (en) | 2008-06-19 |
KR20090083901A (ko) | 2009-08-04 |
MX2009004365A (es) | 2009-05-05 |
CA2668576A1 (en) | 2008-06-19 |
CN101534793A (zh) | 2009-09-16 |
WO2008073193A3 (en) | 2009-03-26 |
US20080124376A1 (en) | 2008-05-29 |
TW200826985A (en) | 2008-07-01 |
ZA200901842B (en) | 2010-05-26 |
JP5586956B2 (ja) | 2014-09-10 |
RU2450802C2 (ru) | 2012-05-20 |
EP2094235A2 (en) | 2009-09-02 |
AU2007332930B2 (en) | 2011-03-17 |
WO2008073193A2 (en) | 2008-06-19 |
JP2010508902A (ja) | 2010-03-25 |
KR101454041B1 (ko) | 2014-10-27 |
RU2009121444A (ru) | 2010-12-20 |
CA2668576C (en) | 2016-03-22 |
CA2914805C (en) | 2017-12-12 |
CA2914805A1 (en) | 2008-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20092101L (no) | Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav. | |
PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
CY1120741T1 (el) | Θεραπεια οζωδους σκληρυνσης | |
CA2711696C (en) | Therapeutic compositions for treatment of ocular inflammatory disorders | |
DK1933869T3 (da) | Anvendelse af IL-23- og IL-17-antagonister til behandling af autoimmun øjenbetændelsessygdom | |
DK1715865T3 (da) | Terapeutisk middel mod hyperlipæmi med pitavastatiner og eicosapentaensyre | |
MX2009004883A (es) | Piridil sulfoximinas multi-substituidas y su uso como insecticidas. | |
BRPI0808775A2 (pt) | compostos e composições como moduladores de atividade de gpr119 | |
NI200900093A (es) | Compuestos que modulan la actividad de c-fms y/o c-kit y uso de los mismos. | |
HN2008000311A (es) | Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida | |
NO20070330L (no) | Retinalderivater og fremgangsmater for anvendelse derav til behandling av synsforstyrrelser | |
MX2010003117A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
TW200745109A (en) | Pyrrolo-pyridine kinase modulators | |
EA201290131A1 (ru) | Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний | |
ECSP11011246A (es) | Métodos para reducir la proliferación y viabilidad de los agentes microbianos | |
WO2007035473A3 (en) | Pharmaceutical delivery device and method for providing ocular treatment | |
BRPI0912252A2 (pt) | dispositivos oftálmicos para liberação controlada de agentes ativos. | |
CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
MX2009013970A (es) | Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos. | |
WO2012047587A3 (en) | Mdm2 inhibitors for treatment of ocular conditions | |
BR112015022161A2 (pt) | implante intraocular contendo prostamida | |
DK2350093T3 (da) | Substituerede 4,5,6,7-tetrahydrothienopyridiner som KCNQ2/3-modulatorer til behandling af smerte, epilepsi og urininkontinens. | |
DK1791428T3 (da) | Sammensætning til behandling af såsæd | |
BRPI0614397A2 (pt) | compostos de pirimidina como moduladores de receptor de serotonina | |
MY170121A (en) | Formulations for the treatment of deep tissue pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |